BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11347559)

  • 1. Medical treatment of uterine fibroids.
    Chavez NF; Stewart EA
    Clin Obstet Gynecol; 2001 Jun; 44(2):372-84. PubMed ID: 11347559
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and Emerging Medical Treatments for Uterine Fibroids.
    Chwalisz K; Taylor H
    Semin Reprod Med; 2017 Nov; 35(6):510-522. PubMed ID: 29100239
    [No Abstract]   [Full Text] [Related]  

  • 3. An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review.
    Bartels CB; Cayton KC; Chuong FS; Holthouser K; Arian SE; Abraham T; Segars JH
    Clin Obstet Gynecol; 2016 Mar; 59(1):30-52. PubMed ID: 26756261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
    Zeng C; Gu M; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life.
    Palomba S; Orio F; Russo T; Falbo A; Amati A; Zullo F
    Fertil Steril; 2004 Aug; 82(2):480-2. PubMed ID: 15302308
    [No Abstract]   [Full Text] [Related]  

  • 6. Uterine fibroids, management and effect on fertility.
    Salman T; Davis C
    Curr Opin Obstet Gynecol; 2010 Aug; 22(4):295-303. PubMed ID: 20610997
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist.
    Donnez J; Dolmans MM
    Fertil Steril; 2020 Oct; 114(4):739-741. PubMed ID: 32854931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surgical treatment of subserosal fibroids: the pros].
    Gillaux C; Panel P
    Gynecol Obstet Fertil; 2011; 39(7-8):458-61. PubMed ID: 21752684
    [No Abstract]   [Full Text] [Related]  

  • 9. Induced hypoestrogenism increases the arterial resistance index of leiomyomata without affecting uterine or carotid arteries.
    Spong CY; Sinow R; Renslo R; Cabus E; Rutgers J; Kletzky OA
    J Assist Reprod Genet; 1995 May; 12(5):338-41. PubMed ID: 8520200
    [No Abstract]   [Full Text] [Related]  

  • 10. [GnRH antagonist].
    Yano T; Taketani Y
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():133-8. PubMed ID: 11235152
    [No Abstract]   [Full Text] [Related]  

  • 11. Etiology and pathophysiology of fibroid tumor disease: diagnosis and current medical and surgical treatment alternatives.
    Marut EL
    Obstet Gynecol Surv; 1989 May; 44(5):308-10. PubMed ID: 2498792
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug treatments for uterine fibroma: rationale].
    Fernandez H; Azoulay C; Rostoker G;
    J Gynecol Obstet Biol Reprod (Paris); 2005 Jun; 34(4):360-405. PubMed ID: 16136663
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
    Adamson GD
    Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of fibroids.
    Sankaran S; Manyonda IT
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of subserosal fibroids: the cons].
    Marret H; Ouldamer L
    Gynecol Obstet Fertil; 2011; 39(7-8):454-7. PubMed ID: 21752689
    [No Abstract]   [Full Text] [Related]  

  • 16. Single or repeated gonadotropin-releasing hormone agonist treatment avoids hysterectomy in premenopausal women with large symptomatic fibroids with no effects on sexual function.
    Perrone AM; Pozzati F; Di Marcoberardino B; Rossi M; Procaccini M; Pellegrini A; Santini D; De Iaco P
    J Obstet Gynaecol Res; 2014 Jan; 40(1):117-24. PubMed ID: 24033631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
    Felberbaum RE; Küpker W; Diedrich K
    Reprod Biomed Online; 2002; 5 Suppl 1():68-72. PubMed ID: 12537785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine fibroids: medical treatment or surgery?
    Lancet; 1986 Nov; 2(8517):1197. PubMed ID: 2877334
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.
    Felberbaum RE; Germer U; Ludwig M; Riethmüller-Winzen H; Heise S; Buttge I; Bauer O; Reissmann T; Engel J; Diedrich K
    Hum Reprod; 1998 Jun; 13(6):1660-8. PubMed ID: 9688409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestins and uterine leiomyoma.
    Schweppe KW
    Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():21-4. PubMed ID: 12227898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.